Sign In
Buy AMRX
$12.88
+0.225 (+1.78%)
At Close: Jun 03, 2026
Best Value Stocks to Buy for March 9th
08:16am, Monday, 09'th Mar 2026
AMRX, VET and NESR made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 9th, 2026.
Amneal to Participate in Upcoming Investor Conference
04:05pm, Thursday, 05'th Mar 2026
BRIDGEWATER, N.J., March 05, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) today announced that Chirag Patel, Co-Chief Executive and President, will participate in a fireside ch
Amneal Pharmaceuticals Q4 Earnings Call Highlights
05:05am, Monday, 02'nd Mar 2026
Amneal Pharmaceuticals (NASDAQ: AMRX) reported fourth-quarter and full-year 2025 results and outlined its 2026 outlook, highlighting growth across the business, expanding complex product launches, and
Amneal (AMRX) Reports Q4 Earnings: What Key Metrics Have to Say
10:30am, Friday, 27'th Feb 2026
While the top- and bottom-line numbers for Amneal (AMRX) give a sense of how the business performed in the quarter ended December 2025, it could be worth looking at how some of its key metrics compare
Amneal Pharmaceuticals, Inc. (AMRX) Q4 2025 Earnings Call Transcript
10:17am, Friday, 27'th Feb 2026
Amneal Pharmaceuticals, Inc. (AMRX) Q4 2025 Earnings Call Transcript
Amneal Pharmaceuticals (AMRX) Q4 Earnings Top Estimates
08:15am, Friday, 27'th Feb 2026
Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.12 per share a year ago.
Amneal Reports Fourth Quarter and Full Year 2025 Financial Results
06:00am, Friday, 27'th Feb 2026
‒ Full Year 2025 Performance Met or Exceeded All Guidance Metrics and 2026 Reflects Another Year of Growth – ‒ Q4 2025 Net Revenue of $814 million ; GAAP Net Income of $35 million ; Diluted Inco
Is Amneal Pharmaceuticals (AMRX) Stock Undervalued Right Now?
10:41am, Monday, 23'rd Feb 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Brokerages Set Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Target Price at $13.80
01:58am, Monday, 16'th Feb 2026
Shares of Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the five research firms that are currently covering the fir
Accessible Health Platforms Gain Scale Across $6T Health and Wellness Market
11:26am, Friday, 13'th Feb 2026
/PRNewswire/ -- Equity-Insider.com News Commentary - The global health and wellness sector is entering 2026 on a trajectory toward $6 trillion in annual
Is Amneal Pharmaceuticals (AMRX) a Great Value Stock Right Now?
10:40am, Thursday, 05'th Feb 2026
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
04:05pm, Wednesday, 28'th Jan 2026
BRIDGEWATER, N.J., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that it has been added to the S&P SmallCap 600® In
Will Amneal (AMRX) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Wednesday, 28'th Jan 2026
Amneal (AMRX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI)
Amneal to Report Fourth Quarter and Full Year 2025 Results on February 27, 2026
08:00am, Tuesday, 27'th Jan 2026
BRIDGEWATER, N.J., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”), today announced that the Company will release its fourth quarter a
